Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorAckermann , Tobias
dc.contributor.authorShokry, Engy
dc.contributor.authorDeshmukh, Ruhi
dc.contributor.authorAnand, Jayanthi
dc.contributor.authorGalbraith, Laura C A
dc.contributor.authorMitchell, Louise
dc.contributor.authorRodriguez-Blanco, Giovanny
dc.contributor.authorVillar, Victor H
dc.contributor.authorSterken, Britt Amber
dc.contributor.authorNixon, Colin
dc.contributor.authorZanivan, Sara
dc.contributor.authorBlyth, Karen
dc.contributor.authorSumpton, David
dc.contributor.authorTardito, Saverio
dc.date.accessioned2025-02-18T15:30:19Z
dc.date.available2025-02-18T15:30:19Z
dc.date.issued2024-11-11
dc.identifier309454722
dc.identifier2f3dd4c0-0d7c-4eea-9843-e72cf9ce4c12
dc.identifier85205803809
dc.identifier.citationAckermann , T , Shokry , E , Deshmukh , R , Anand , J , Galbraith , L C A , Mitchell , L , Rodriguez-Blanco , G , Villar , V H , Sterken , B A , Nixon , C , Zanivan , S , Blyth , K , Sumpton , D & Tardito , S 2024 , ' Breast cancer secretes anti-ferroptotic MUFAs and depends on selenoprotein synthesis for metastasis ' , Embo Molecular Medicine , vol. 16 , no. 11 , pp. 2749-2774 . https://doi.org/10.1038/s44321-024-00142-xen
dc.identifier.issn1757-4676
dc.identifier.otherORCID: /0000-0003-2837-5018/work/170403490
dc.identifier.urihttps://hdl.handle.net/10023/31435
dc.descriptionFunding: This work was funded by Cancer Research UK core funding awarded to the CRUK Scotland Institute (grant number A31287), Stand Up to Cancer campaign for CRUK awarded to SZ (grant number A29800), Breast Cancer Now awarded to SZ (grant number 2018NovPR102), Cancer Research UK core funding awarded to KB (grant number A29799) and Cancer Research UK core funding awarded to ST (grant number A23982).en
dc.description.abstractThe limited availability of therapeutic options for patients with triple-negative breast cancer (TNBC) contributes to the high rate of metastatic recurrence and poor prognosis. Ferroptosis is a type of cell death caused by iron-dependent lipid peroxidation and counteracted by the antioxidant activity of the selenoprotein GPX4. Here, we show that TNBC cells secrete an anti-ferroptotic factor in the extracellular environment when cultured at high cell densities but are primed to ferroptosis when forming colonies at low density. We found that secretion of the anti-ferroptotic factors, identified as monounsaturated fatty acid (MUFA) containing lipids, and the vulnerability to ferroptosis of single cells depends on the low expression of stearyl-CoA desaturase (SCD) that is proportional to cell density. Finally, we show that the inhibition of Sec-tRNAsec biosynthesis, an essential step for selenoprotein production, causes ferroptosis and impairs the lung seeding of circulating TNBC cells that are no longer protected by the MUFA-rich environment of the primary tumour.
dc.format.extent26
dc.format.extent3871042
dc.language.isoeng
dc.relation.ispartofEmbo Molecular Medicineen
dc.rights© The Author(s) 2024. This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.en
dc.subjectBreast canceren
dc.subjectFerroptosisen
dc.subjectLipid metabolismen
dc.subjectMetastasisen
dc.subjectSelenium metabolismen
dc.subjectDASen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectMCCen
dc.titleBreast cancer secretes anti-ferroptotic MUFAs and depends on selenoprotein synthesis for metastasisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of St Andrews.Cellular Medicine Divisionen
dc.contributor.institutionUniversity of St Andrews.Sir James Mackenzie Institute for Early Diagnosisen
dc.contributor.institutionUniversity of St Andrews.School of Medicineen
dc.identifier.doi10.1038/s44321-024-00142-x
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record